Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Katarzyna Gajewska-Wicher"'
Autor:
Bożena Cybulska-Stopa, Barbara Ziółkowska, Łukasz Galus, Tomasz Kubiatowski, Stanisław Kieszko, Karolina Piejko, Jacek Mackiewicz, Piotr Rutkowski, Anna Drosik-Kwaśniewska, Jacek Calik, Grażyna Kamińska-Winciorek, Marcin Ziętek, Anna M. Czarnecka, Renata Pacholczak-Madej, Paweł Rogala, Katarzyna Gajewska-Wicher, Rafał Suwiński, Janusz Rolski, Agata Sałek-Zań, Natasza Kempa-Kamińska
Publikováno v:
Immunotherapy. 13:297-307
Aim: To evaluate treatment results in advanced/metastatic melanoma patients treated with anti-PD-1 immunotherapy in routine practice in oncology centers in Poland. Methods: Multicenter retrospective analysis included 499 patients with unresectable/me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75481f1f9c5cc0cca549a49f8bad084d
https://doi.org/10.2217/imt-2020-0217
https://doi.org/10.2217/imt-2020-0217
Autor:
Łukasz Galus, Robert Dziura, Anna Drosik-Kwaśniewska, Rafał Suwiński, Stanisław Kieszko, Jacek Mackiewicz, Natasza Kempa-Kamińska, Agata Sałek-Zań, Bożena Cybulska-Stopa, Karolina Piejko, Grażyna Kamińska-Winciorek, Marcin Ziętek, Joanna Seredyńska, Jacek Calik, Kamila Gądek, Barbara Ziółkowska, Katarzyna Gajewska-Wicher, Tomasz Kubiatowski, Piotr Rutkowski, Anna M. Czarnecka
Publikováno v:
Journal of Clinical Oncology. 39:e21514-e21514
e21514 Background: Anti-programmed cell death-1 antibodies (anti-PD-1) have become a standard treatment option for melanoma patients. Currently, two anti-PD-1 antibodies are registered in the treatment of melanoma patients: nivolumab and pembrolizuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c672e737238540bb034ade22ae98e34
https://doi.org/10.1200/jco.2021.39.15_suppl.e21514
https://doi.org/10.1200/jco.2021.39.15_suppl.e21514